Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AXS Vecta 71 Intermediate Catheter, AXS Vecta 74 Intermediate Catheter

K-Number: K200206 · 2020-02-27

ApplicantStryker Neurovascular
Decision Date2020-02-27
Product CodeQJP
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

AXS Vecta 71 Intermediate Catheter, AXS Vecta 74 Intermediate Catheter is a medical device manufactured by Stryker Neurovascular. It received FDA 510(k) clearance on 2020-02-27 under approval number K200206. The device is classified under product code QJP. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AXS Vecta 71 Intermediate Catheter, AXS Vecta 74 Intermediate Catheter?

AXS Vecta 71 Intermediate Catheter, AXS Vecta 74 Intermediate Catheter is a medical device that received FDA 510(k) clearance on 2020-02-27. It is manufactured by Stryker Neurovascular. The 510(k) number is K200206.

When was AXS Vecta 71 Intermediate Catheter, AXS Vecta 74 Intermediate Catheter approved by the FDA?

AXS Vecta 71 Intermediate Catheter, AXS Vecta 74 Intermediate Catheter received FDA 510(k) clearance on 2020-02-27, under approval number K200206.

What company makes AXS Vecta 71 Intermediate Catheter, AXS Vecta 74 Intermediate Catheter?

AXS Vecta 71 Intermediate Catheter, AXS Vecta 74 Intermediate Catheter is manufactured by Stryker Neurovascular.

What is the FDA product code for AXS Vecta 71 Intermediate Catheter, AXS Vecta 74 Intermediate Catheter?

The FDA product code for AXS Vecta 71 Intermediate Catheter, AXS Vecta 74 Intermediate Catheter is QJP.

Related Clinical Trials

NCT02761889 Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer COMPLETED NCT04035642 Single-Dose Image-Guided Radiotherapy With Urethral Sparing and DIL Boost for Intermediate-Risk Prostate Cancer (PROSINT II) RECRUITING NCT04790370 Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism ACTIVE_NOT_RECRUITING NCT06453876 Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II) NOT_YET_RECRUITING NCT04057352 Citadel Embolization Device Study ACTIVE_NOT_RECRUITING

Other Devices by Stryker Neurovascular

K161429Target Detachable Coils K153658Target Detachable Coils K160096InZone Detachment System K163259AXS Offset Delivery Assist Catheter K190833AXS Vecta Aspiration Catheter K193034AXS Infinity LS Plus Long Sheath

View all 26 devices →

Related Devices (Code: QJP)

K203043Route 92 Medical 070 Access SystemRoute 92 Medical, Inc. K201682RIST Radial Access CatheterRist Neurovascular, Inc. K201518Route 92 Medical 088 Access SystemRoute 92 Medical K201076Anchor Dual Lumen Guidewire CatheterAqure Medical, Inc. K200910BOSS Balloon Guide CatheterMarblehead Medical K200417RIST Radial Access CatheterRist Neurovascular, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑